1,785
Views
0
CrossRef citations to date
0
Altmetric
Case Report

System degeneration in an MM1-type sporadic Creutzfeldt-Jakob disease case with an unusually prolonged akinetic mutism state

ORCID Icon, , , , , , , , & show all
Pages 12-20 | Received 25 Sep 2020, Accepted 22 Dec 2020, Published online: 20 Jan 2021

References

  • Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224–233.
  • Iwasaki Y. Creutzfeldt-Jakob disease. Neuropathology. 2017;37:174–188.
  • Iwasaki Y. The Braak hypothesis in prion disease with a focus on Creutzfeldt-Jakob disease. Neuropathology. 2020;40:436–449.
  • Iwasaki Y, Tatsumi S, Mimuro M, et al. Relation between clinical findings and progression of cerebral cortical pathology in MM1-type sporadic Creutzfeldt-Jakob disease: proposed staging of cerebral cortical pathology. J Neurol Sci. 2014;341:97–104.
  • Iwasaki Y, Yoshida M, Hashizume Y, et al. Clinicopathologic characteristics of sporadic Japanese Creutzfeldt-Jakob disease classified according to prion protein gene polymorphism and prion protein type. Acta Neuropathol. 2006;112:561–571.
  • Iwasaki Y, Hashizume Y, Yoshida M, et al. Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 2005;109:557–566.
  • Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259.
  • Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389–404.
  • Iwasaki Y, Mimuro M, Yoshida M, et al. Survival to akinetic mutism state in Japanese cases of MM1-type sporadic Creutzfeldt-Jakob disease is similar to Caucasians. Eur J Neurol. 2011;18:999–1002.
  • Iwasaki Y, Akagi A, Mimuro M, et al. Factors influencing the survival period in Japanese patients with sporadic Creutzfeldt-Jakob disease. J Neurol Sci. 2015;357:63–68.
  • Iwasaki Y, Mori K, Ito M, et al. Gastrostomy in patients with prion disease. Prion. 2017;11:186–194.
  • Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;5:459–466.
  • Iwasaki Y, Kato H, Ando T, et al. MM1-type sporadic Creutzfeldt-Jakob disease with 1 month total disease duration and early pathologic indicators. Neuropathology. 2017;37:420–425.
  • Iwasaki Y, Yoshida M, Hashizume Y, et al. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 2005;110:490–500.
  • Iwasaki Y, Mimuro M, Yoshida M, et al. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease. Neuropathology. 2008;28:51–61.
  • Mizutani T, Okumura A, Oda M, et al. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol Neurosurg Psychiatry. 1981;44:103–115.
  • Iwasaki Y, Iijima M, Kimura S, et al. Autopsy case of sporadic Creutzfeldt-Jakob disease presenting with signs suggestive of brainstem and spinal cord involvement. Neuropathology. 2006;26:550–556.
  • Kobayashi A, Iwasaki Y, Otsuka H, et al. Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein. Acta Neuropathol Commun. 2013;13:74.